{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:13:24Z","timestamp":1773281604551,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcardioanesthesia.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1053\/j.jvca.2015.12.013","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T02:27:12Z","timestamp":1450146432000},"page":"1624-1626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Use of Oral Droxidopa to Improve Arterial Pressure and Reduce Vasoactive Drug Requirements During Persistent Vasoplegic Syndrome After Cardiac Transplantation"],"prefix":"10.1053","volume":"30","author":[{"given":"M. Tracy","family":"Zundel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent T.","family":"Boettcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel T.","family":"Feih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nunzio","family":"Gaglianello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Pagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2015.12.013_bib1","first-page":"619","article-title":"Vasoplegic syndrome after open heart surgery","volume":"39","author":"Gomes","year":"1998","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1053\/j.jvca.2015.12.013_bib2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.semtcvs.2010.09.007","article-title":"Vasoplegia during cardiac surgery: Current concepts and management","volume":"22","author":"Fischer","year":"2010","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2015.12.013_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0022-5223(96)70458-0","article-title":"Human cytokine responses to cardiac transplantation and coronary artery bypass grafting","volume":"111","author":"Wan","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2015.12.013_bib4","first-page":"529","article-title":"Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass","volume":"51","author":"Kirklin","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2015.12.013_bib5","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1586\/erc.11.160","article-title":"Methylene blue: Potential use of an antique molecule in vasoplegic syndrome during cardiac surgery","volume":"9","author":"Lenglet","year":"2011","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1053\/j.jvca.2015.12.013_bib6","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-5223(98)70049-2","article-title":"Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent","volume":"116","author":"Argenziano","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2015.12.013_bib7","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0003-4975(01)02486-9","article-title":"Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function","volume":"71","author":"Mekontso-Dessap","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2015.12.013_bib8","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0022-5223(02)73284-4","article-title":"Methylene blue: The drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?","volume":"125","author":"Leyh","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2015.12.013_bib9","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.108.814533","article-title":"Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome","volume":"120","author":"Levin","year":"2009","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2015.12.013_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejcts.2003.11.032","article-title":"Risk factors and outcomes for \u2018vasoplegia syndrome\u2019 following cardiac transplantation","volume":"25","author":"Bryne","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2015.12.013_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1527-3466.2006.00189.x","article-title":"L-Dihydroxyphenylserine (L-DOPS): A norepinephrine prodrug","volume":"24","author":"Goldstein","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1053\/j.jvca.2015.12.013_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10286-007-1002-2","article-title":"L-dihydroxyphenylserine (droxidopa): A new therapy for neurogenic orthostatic hypotension: The US experience","volume":"Suppl 1","author":"Kaufmann","year":"2008","journal-title":"Clin Auton Res 18"},{"key":"10.1053\/j.jvca.2015.12.013_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","article-title":"Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa","volume":"65","author":"Biaggioni","year":"2015","journal-title":"Hypertension"},{"key":"10.1053\/j.jvca.2015.12.013_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/HYPERTENSIONAHA.114.04204","article-title":"Prospects for droxidopa in neurogenic orthostatic hypotension","volume":"65","author":"Ross","year":"2015","journal-title":"Hypertension"},{"key":"10.1053\/j.jvca.2015.12.013_bib15","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1212\/WNL.47.6.1414","article-title":"The treatment of postprandial hypotension in autonomic failure with 3,4-DL-threo-dihydroxyphenylserine","volume":"47","author":"Freeman","year":"1996","journal-title":"Neurology"},{"key":"10.1053\/j.jvca.2015.12.013_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1196\/annals.1296.064","article-title":"Congenital dopamine-beta-hydroxylase deficiency in humans","volume":"1018","author":"Timmers","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1053\/j.jvca.2015.12.013_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00002826-199708000-00010","article-title":"Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy","volume":"20","author":"Yamamoto","year":"1997","journal-title":"Clin Neuropharmacol"},{"key":"10.1053\/j.jvca.2015.12.013_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02291133","article-title":"The effects of the noradrenaline precursor, L-threo-3,4-dihydroxyphenylserine, in children with orthostatic intolerance","volume":"6","author":"Tanaka","year":"1996","journal-title":"Clin Auton Res"},{"key":"10.1053\/j.jvca.2015.12.013_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1476-5381.1950.tb00593.x","article-title":"The formation of noradrenaline from dihydroxyphenylserine","volume":"5","author":"Blaschko","year":"1950","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1053\/j.jvca.2015.12.013_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10286-004-0221-z","article-title":"Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure","volume":"14","author":"Goldstein","year":"2004","journal-title":"Clin Auton Res"},{"key":"10.1053\/j.jvca.2015.12.013_bib21","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0140-6736(87)91318-3","article-title":"Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in dopamine-beta-hydroxylase deficiency","volume":"2","author":"Man in \u2018t Veld","year":"1987","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2015.12.013_bib22","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/0006-2952(87)90223-1","article-title":"Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa","volume":"36","author":"Kato","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/j.jvca.2015.12.013_bib23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015908785777193","article-title":"Functional neuroanatomy of the noradreneregic locus coeruleus: Its roles in the regulation of arousal and autonomic function part II: Physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans","volume":"6","author":"Samuels","year":"2008","journal-title":"Curr Neuropharmacol"},{"key":"10.1053\/j.jvca.2015.12.013_bib24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S1053-2498(01)00299-6","article-title":"Hypotension, acidosis, and vasodilatation syndrome post-heart transplant: Prognostic variables and outcomes","volume":"20","author":"Chemmalakuzhy","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2015.12.013_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/1074248408317709","article-title":"Oral midodrine is effective for the treatment of hypotension associated with carotid artery stenting","volume":"13","author":"Sharma","year":"2008","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1053\/j.jvca.2015.12.013_bib26","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jcrc.2013.05.021","article-title":"Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions","volume":"28","author":"Levine","year":"2013","journal-title":"J Crit Care"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307701500974X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307701500974X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T01:54:37Z","timestamp":1537149277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105307701500974X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S105307701500974X"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2015.12.013","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Oral Droxidopa to Improve Arterial Pressure and Reduce Vasoactive Drug Requirements During Persistent Vasoplegic Syndrome After Cardiac Transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2015.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}